{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Levalbuterol%2FLevosalbutamol&page=2", "query": { "intervention": "Levalbuterol/Levosalbutamol", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 387, "total_pages": 39, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Levalbuterol%2FLevosalbutamol&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Levalbuterol%2FLevosalbutamol&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-03T01:27:03.162Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03380429", "title": "A Clinical Study to Evaluate the Effect of the Connected Inhaler System (CIS) on Adherence to Maintenance Therapy in Poorly Controlled Asthmatic Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "RELVAR/BREO", "type": "DRUG" }, { "name": "Salbutamol", "type": "DRUG" }, { "name": "Smart phone app", "type": "DEVICE" }, { "name": "HCP Dashboard", "type": "DEVICE" }, { "name": "Sensors", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 437, "start_date": "2018-01-31", "completion_date": "2019-01-24", "has_results": true, "last_update_posted_date": "2021-04-12", "last_synced_at": "2026-10-03T01:27:03.162Z", "location_count": 11, "location_summary": "Aventura, Florida • Miami, Florida • Flossmoor, Illinois + 8 more", "locations": [ { "city": "Aventura", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Flossmoor", "state": "Illinois" }, { "city": "Glenview", "state": "Illinois" }, { "city": "Hazelwood", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT03380429" }, { "nct_id": "NCT02141854", "title": "Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "FS MDPI", "type": "DRUG" }, { "name": "Fp MDPI", "type": "DRUG" }, { "name": "Placebo MDPI", "type": "DRUG" }, { "name": "Albuterol/salmeterol HFA MDI", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 882, "start_date": "2014-06", "completion_date": "2015-09", "has_results": true, "last_update_posted_date": "2021-11-09", "last_synced_at": "2026-10-03T01:27:03.162Z", "location_count": 85, "location_summary": "Birmingham, Alabama • Little Rock, Alaska • Phoenix, Arizona + 74 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Alaska" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Costa Mesa", "state": "California" }, { "city": "Encinitas", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02141854" }, { "nct_id": "NCT02108743", "title": "Albuterol and Dynamic Hyperinflation in Idiopathic Pulmonary Arterial Hypertension", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Idiopathic Pulmonary Arterial Hypertension." ], "interventions": [ { "name": "Albuterol.", "type": "DRUG" }, { "name": "Normal saline placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "American Medical Association Foundation", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 0, "start_date": "2014-06", "completion_date": "2016-10", "has_results": false, "last_update_posted_date": "2015-12-30", "last_synced_at": "2026-10-03T01:27:03.162Z", "location_count": 1, "location_summary": "New Orleans, Louisiana", "locations": [ { "city": "New Orleans", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT02108743" }, { "nct_id": "NCT01302587", "title": "A Study to Evaluate the Integrated Dose Counter on an Albuterol Hydrofluoroalkane (HFA) Metered Dose Inhaler (MDI)", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Asthma", "Chronic Obstructive Pulmonary Disease (COPD)", "Emphysema", "Chronic Bronchitis" ], "interventions": [ { "name": "Albuterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": null, "sex": "ALL", "summary": "4 Years and older" }, "enrollment_count": 306, "start_date": "2011-03", "completion_date": "2011-06", "has_results": false, "last_update_posted_date": "2012-06-22", "last_synced_at": "2026-10-03T01:27:03.162Z", "location_count": 25, "location_summary": "Glendale, Arizona • Mission Viejo, California • Orange, California + 22 more", "locations": [ { "city": "Glendale", "state": "Arizona" }, { "city": "Mission Viejo", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Wheat Ridge", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01302587" }, { "nct_id": "NCT00064402", "title": "Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease", "Chronic Bronchitis", "Emphysema" ], "interventions": [ { "name": "arformoterol tartrate inhalation solution", "type": "DRUG" }, { "name": "Salmeterol", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "35 Years", "maximum_age": null, "sex": "ALL", "summary": "35 Years and older" }, "enrollment_count": 741, "start_date": "2002-04", "completion_date": "2004-03", "has_results": false, "last_update_posted_date": "2012-02-22", "last_synced_at": "2026-10-03T01:27:03.162Z", "location_count": 65, "location_summary": "Jasper, Alabama • Phoenix, Arizona • Tucson, Arizona + 59 more", "locations": [ { "city": "Jasper", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Fair Oaks", "state": "California" }, { "city": "Fresno", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00064402" }, { "nct_id": "NCT00529529", "title": "Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Indacaterol 300 μg", "type": "DRUG" }, { "name": "Salmeterol 50 μg", "type": "DRUG" }, { "name": "Placebo to indacaterol", "type": "DRUG" }, { "name": "Placebo to salmeterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 805, "start_date": "2007-09", "completion_date": "2008-08", "has_results": true, "last_update_posted_date": "2011-08-29", "last_synced_at": "2026-10-03T01:27:03.162Z", "location_count": 56, "location_summary": "Glendale, Arizona • Phoenix, Arizona • Encinitas, California + 44 more", "locations": [ { "city": "Glendale", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Encinitas", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00529529" }, { "nct_id": "NCT03890666", "title": "A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Participants13 Years or Older With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Albuterol eMDPI DS", "type": "DRUG" }, { "name": "albuterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": null, "sex": "ALL", "summary": "13 Years and older" }, "enrollment_count": 333, "start_date": "2020-10-26", "completion_date": "2021-10-04", "has_results": true, "last_update_posted_date": "2026-03-19", "last_synced_at": "2026-10-03T01:27:03.162Z", "location_count": 29, "location_summary": "Birmingham, Alabama • Los Angeles, California • Stockton, California + 24 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Stockton", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT03890666" }, { "nct_id": "NCT02458482", "title": "Trial of AccuPAP Device Versus Standard Nebulizer Therapy in Acute Asthma Exacerbation in Children", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "AccuPAP", "type": "DEVICE" }, { "name": "Albuterol and Ipratropium Continuous Nebulizer", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "Vanderbilt University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Years to 17 Years" }, "enrollment_count": 0, "start_date": "2015-07", "completion_date": "2020-11-11", "has_results": false, "last_update_posted_date": "2020-11-13", "last_synced_at": "2026-10-03T01:27:03.162Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT02458482" }, { "nct_id": "NCT03556683", "title": "Phase I Assessment of Hypertonic Saline in Moderate to Severe Asthmatics", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Moderate to Severe Asthma" ], "interventions": [ { "name": "3% Hypertonic Saline", "type": "DEVICE" }, { "name": "7% Hypertonic Saline", "type": "DEVICE" }, { "name": "Salbutamol", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 24, "start_date": "2018-10-01", "completion_date": "2024-06-06", "has_results": true, "last_update_posted_date": "2025-08-05", "last_synced_at": "2026-10-03T01:27:03.162Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03556683" }, { "nct_id": "NCT00649987", "title": "Fed Study of Albuterol Sulfate Extended-Release Tablets 8 mg and VoSpire® ER Tablets 8 mg", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Albuterol Sulfate Extended-Release Tablets 8 mg", "type": "DRUG" }, { "name": "VoSpire® ER Tablets 8 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mylan Pharmaceuticals Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 21, "start_date": "2005-09", "completion_date": "2005-10", "has_results": false, "last_update_posted_date": "2024-04-24", "last_synced_at": "2026-10-03T01:27:03.162Z", "location_count": 1, "location_summary": "Fargo, North Dakota", "locations": [ { "city": "Fargo", "state": "North Dakota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00649987" } ] }